Agent Bell pulled Subject Seven’s record before Claire returned upstairs.
The file identified a girl named Abigail Mercer.
Born fifteen years earlier.
Vector administration at age nine months.
Activation at age eleven.
Tumor development six months later.
Therapeutic cellular infusion.
Then one final entry.
DECEASED.
Claire stared at Samuel.
“You said she can verify the batch.”
“She can.”
“The record says she died.”
“The record lies.”
Bell leaned forward.
“You know she survived?”
“I saw her afterward.”
“When?”
“Three years ago.”
“Where?”
Samuel refused to answer.
Bell’s patience thinned.
“You are not negotiating anymore.”
Samuel looked almost amused.
“I am not protecting myself.”
“Then who?”
“Abigail.”
Claire understood before Bell did.
“If NorthStar thinks she is dead, she is safe.”
Samuel nodded.
“Or was.”
“And Price knows where she is?”
“He may.”
“Why?”
“Because he arranged her disappearance.”
Bell stared.
Samuel explained that Abigail’s treatment became the first proof the engineered immune cells could eradicate an activated tumor.
NorthStar wanted to continue monitoring her indefinitely.
Abigail’s mother discovered the illegal research and threatened to go public.
Price offered a deal.
He would erase Abigail from the program and create records showing she had died.
In return, her mother would disappear with her and remain silent.
Claire shook her head.
“That sounds too generous for him.”
“It was not generosity.”
“What did he gain?”
“The only living successful subject disappeared from regulators.”
Bell asked where Abigail and her mother had gone.
Samuel gave him a town in Vermont.
A name different from Mercer.
Anna Brooks.
“She owns a bookstore.”
Claire almost laughed.
After fake clinics, hidden labs, engineered cancers, and covert monitoring, the idea of a bookstore felt impossibly ordinary.
Bell immediately contacted agents in Vermont.
Claire returned to Sophie’s room.
Sophie was awake, watching Daniel assemble a puzzle incorrectly.
“You’re forcing it,” she told him.
“I’m exploring alternatives.”
“That piece is sky.”
“It could be lake.”
“It has a cloud.”
“Reflective lake.”
Sophie looked at Claire.
“Help him.”
“I’m afraid he’s beyond help.”
Sophie smiled.
Claire sat beside her.
“How are you feeling?”
“Less pukey.”
“A medical term.”
“Dr. Shah taught me.”
Daniel looked up.
“She absolutely did not.”
Eric entered with two cups of coffee.
His shaved head made him look strangely younger.
He handed one to Claire.
“What did Samuel say?”
Claire told them about the three cell batches.
Daniel stopped joking.
“And the one delivered here has no safety switch.”
“Yes.”
“So it’s useless.”
“Too dangerous.”
Eric frowned.
“And Subject Seven?”
“Alive.”
He stared.
“The file says dead.”
“Fabricated.”
Eric sat.
“My entire life is turning into footnotes saying fabricated.”
Sophie looked at him.
“That was kind of funny.”
“Thank you.”
Agent Bell called two hours later.
Federal agents found the bookstore.
Anna Brooks was there.
Her daughter was not.
Abigail had disappeared the previous afternoon.
Security camera footage showed her leaving voluntarily with a man.
Leonard Price.
Claire’s stomach tightened.
“She went with him?”
Bell nodded through the video call.
“No visible force.”
“Why would she?”
Samuel answered when Bell confronted him.
“Because she thinks Price saved her life.”
Claire stared through the glass wall at the interview room.
“He did?”
“In part.”
Samuel explained that during Abigail’s treatment, severe toxicity developed.
NorthStar researchers hesitated to use the suicide switch because they feared destroying the therapeutic cells too early.
Price overruled them.
He ordered the trigger drug administered.
The engineered cells shut down.
Abigail survived.
From her family’s perspective, Price had intervened when others would not.
“Did he then help fake her death?” Bell asked.
“Yes.”
“So she trusts him.”
“Possibly.”
“Enough to leave with him.”
Samuel nodded.
That made Abigail not merely a victim.
She was a potential ally for Price.
Dr. Shah reviewed Abigail’s old data.
Her tumor had disappeared completely after cellular therapy.
No recurrence in the available three years of follow-up.
Claire stared at the graph.
“It worked.”
“Yes.”
“Then that is what Sophie needs.”
“Possibly.”
The word no longer irritated Claire.
It had become medicine’s most honest word.
Sophie listened.
“Did Abigail lose her hair?”
Dr. Shah looked surprised.
“Probably.”
“Did it grow back?”
“Yes.”
Sophie rubbed her bare scalp.
“Good.”
Bell’s team tracked Price’s car north.
Then west.
Then lost it.
License-plate cameras suggested he switched vehicles.
Abigail’s phone remained off.
Anna Brooks refused federal protection until Bell told her Sophie’s name.
Then she agreed to speak.
The video call happened that evening.
Anna appeared older than Claire expected.
Gray-blond hair.
Deep circles beneath her eyes.
She looked directly at Sophie’s image on the screen.
“She’s ten?”
“Yes.”
Anna closed her eyes.
“Abby was eleven when they activated her.”
Sophie sat beside Claire.
“Did she get better?”
“Yes.”
“Completely?”
“As far as we know.”
Sophie nodded as though taking notes.
“Was she scared?”
Anna’s face softened.
“Very.”
“Did she act like she wasn’t?”
“All the time.”
Sophie looked satisfied.
“Okay.”
Claire asked why Abigail trusted Leonard Price.
Anna hesitated.
“Because he was the only person inside NorthStar who seemed willing to protect her.”
Samuel had described Price as architect of the later program.
Anna’s description complicated that.
“He authorized the research,” Bell said.
“I learned that later.”
“Did Abigail?”
“Yes.”
“Then why leave with him?”
Anna looked frightened.
“Because Leonard told her there was another child like her.”
Sophie.
Claire felt the implication.
“He said Sophie needs Abigail’s cells?”
“No.”
“What did he say?”
“That only Abigail could tell which batch was safe.”
Samuel had said the same.
Bell looked toward Claire.
“Price may actually be trying to help.”
Daniel shook his head.
“Or he knows that makes Abigail come willingly.”
Both could be true.
Eric asked Anna one question.
“Did Price ever mention my father?”
Her expression hardened.
“Constantly.”
“In what way?”
“He hated him.”
Samuel and Price had not been partners in any simple sense.
They had begun as collaborators.
Samuel wanted to eliminate inherited cancer risk.
Price wanted to turn the platform into a commercial therapy.
After Maya died, Samuel tried to halt clinical work.
Price believed abandoning the research would make Maya’s death meaningless.
“He said Samuel was willing to sacrifice one child for data,” Anna recalled. “Then became a coward when the data looked promising.”
Claire felt disgust at both men.
Each had found a philosophy that justified using children.
Samuel in the name of scientific rescue.
Price in the name of not wasting previous harm.
Anna continued.
“Leonard genuinely believed what he was doing would save millions someday.”
Claire almost laughed.
“Did he ever ask the children if they wanted to save millions?”
Anna’s silence answered.
A breakthrough came shortly before midnight.
Abigail turned on her phone.
One text reached her mother.
I’m okay. Price says Sophie’s batch was switched. Don’t trust Samuel.
Then the phone went dark again.
Samuel read the message.
His face became cold.
“What?” Claire asked.
“He is lying.”
“How do you know?”
“Because I decoded the vial batch.”
“You could be lying.”
“Yes.”
Claire appreciated the answer more than denial.
Bell put photographs of the six vials on the table.
“If Price says the batch was switched, what could that mean?”
Samuel examined them again.
“The external labels can be changed.”
“What cannot?”
“Cryogenic caps have manufacturing microcodes.”
Dr. Shah arranged magnified photographs.
Under ultraviolet imaging, tiny etched numbers became visible.
Samuel read them.
Then stopped.
Claire saw it.
“What?”
He picked up another image.
Then another.
“The labels were switched.”
Bell stared.
“So Price is telling the truth?”
“About this.”
The vial labeled unswitched actually contained the safety-controlled therapeutic cells.
The supposedly safe batch identifier had been placed on the dangerous version.
Someone had wanted doctors to reject the correct treatment.
Claire stared at Samuel.
“You decoded the outside label and told us it was dangerous.”
“Yes.”
“You almost cost Sophie the treatment.”
“Yes.”
“Was that incompetence or intentional?”
Samuel met her gaze.
“Incompetence.”
Claire believed him only because the admission clearly hurt.
Dr. Shah refused to rely on labels at all.
Her laboratory began functional testing.
They exposed samples to the suicide-trigger medication.
Four vials responded exactly as a controlled therapeutic batch should.
Two did not.
The distinction was real.
They now had enough cells for treatment.
Claire stared at Shah.
“When?”
“Not yet.”
Her heart sank.
“What else?”
“We need to know whether Sophie’s healthy tissues express enough receptor to make treatment dangerous.”
Testing required biopsied tissue, stored blood samples, and advanced analysis.
They could accelerate it.
Not eliminate uncertainty.
Sophie listened without complaint.
Then asked, “If the cancer gets worse while everybody studies everything, does that matter?”
“Yes,” Shah said.
“How long can we wait?”
“A few days safely. Not weeks.”
Sophie looked at Claire.
“So three days again.”
The original procedure date was approaching.
Perhaps whoever designed the timeline understood the biological window better than anyone realized.
At 2:00 a.m., Abigail called her mother.
This time federal agents traced the connection quickly.
Bell joined the call.
Abigail’s voice sounded young but composed.
“I’m with Leonard because he has something you need.”
“What?”
“A sample from me.”
“For Sophie?”
“Yes.”
“What kind?”
“My post-treatment marrow.”
Dr. Shah’s expression changed when Bell relayed it.
Abigail’s surviving healthy cells could reveal which tissues retained the synthetic receptor after therapy.
They offered a living comparison no laboratory reconstruction could match.
“Where are you?” Bell asked.
Abigail ignored him.
“Samuel told you the cells have a suicide switch?”
“Yes.”
“He built that after Maya.”
Samuel closed his eyes.
Abigail continued.
“Leonard made him include it. Samuel didn’t want it.”
Claire looked at Samuel through the glass.
Another truth.
Another omission.
“Is that accurate?” she asked.
He nodded.
“I believed it reduced efficacy.”
Claire laughed bitterly.
“So Price saved Abigail because he overruled you.”
“Yes.”
The moral lines refused to stay simple.
Samuel had created the original danger.
Price expanded the unethical program.
Samuel added later safety mechanisms reluctantly.
Price used them and saved a child.
Then Price authorized activation experiments that endangered more children.
No one fit cleanly into hero or monster.
Except the children, who had never chosen any of it.
Abigail gave Bell coordinates.
A rural medical storage facility.
“We’ll meet you there.”
Bell asked whether Price was forcing her.
“No.”
“Can he hear you?”
“Yes.”
“Why won’t he speak?”
A pause.
Then a man’s voice came through.
Leonard Price.
“Because Agent Bell, once I do, you stop listening and start negotiating.”
Bell’s face hardened.
“You authorized illegal experiments on children.”
“Yes.”
Sophie stared at the speaker.
Price continued.
“And if you arrest me before I tell Dr. Shah what NorthStar changed in the final protocol, Sophie Morgan may die.”
Claire stepped toward the phone.
“You have ten seconds to say something useful.”
Price paused.
Then spoke directly to her.
“The tumors are not the endpoint.”
Claire’s skin went cold.
“What is?”
“The immune response after tumor destruction.”
Dr. Shah leaned toward the phone.
“Explain.”
“SV-2 was designed to create a receptor only in cells carrying malignant pathway activation.”
“That would make the therapy tumor-specific.”
“Yes.”
“But?”
“SV-2A altered the activation threshold.”
Samuel stood.
“No.”
Price heard him.
“You never saw the final construct, Samuel.”
“What did you change?”
“We made receptor expression systemic under inflammatory stress.”
Dr. Shah went pale.
Claire looked at her.
“What does that mean?”
Shah answered slowly.
“If Sophie receives the engineered immune cells and then develops a strong inflammatory response…”
Price finished the sentence.
“Healthy tissues could begin expressing the target.”
Daniel stared.
“And the treatment would attack them.”
“Yes.”
Claire’s hands turned cold.
“So the suicide switch matters.”
“More than anyone realizes.”
Price continued.
The trigger drug could stop the cells.
But timing was critical.
Too early and the cancer survived.
Too late and organ damage became irreversible.
“How do you know the timing?” Shah asked.
Price’s answer came quietly.
“Abigail.”
Claire stared at the phone.
“You did this to her.”
“We learned it from her.”
Abigail’s voice returned.
“I almost died.”
Sophie whispered, “But you didn’t.”
“No.”
“How did they know when to stop it?”
“They didn’t.”
A pause.
“My mom did.”
Anna, listening remotely, began crying.
Abigail explained that during her treatment, monitors showed fever, liver injury, and neurological changes.
Researchers debated.
Anna watched her daughter deteriorate and demanded the kill switch be activated.
Price listened.
Samuel did not.
Price overruled him.
Abigail survived.
Claire looked at Samuel.
Maya’s death had not changed him enough.
Abigail nearly had.
Price gave Bell the storage facility coordinates again.
“Bring Dr. Shah. Bring no tactical team inside.”
Bell laughed once.
“That is not happening.”
“Then I transmit the protocol and leave.”
“Do that now.”
“I need confirmation Sophie has the correct cells.”
“We confirmed them.”
“No. You confirmed the kill switch. You did not confirm the receptor-binding sequence.”
Dr. Shah looked sharply at Bell.
Price was right.
Another test was required.
He possessed Abigail’s sample, the only known successful comparison.
Bell agreed to a controlled meeting.
No promises.
No immunity.
At dawn, teams surrounded the rural facility.
Dr. Shah went inside with Bell.
Claire remained at the hospital.
So did Eric.
Samuel was transported under guard but kept outside.
Forty minutes passed.
Then Bell called.
“We have Abigail.”
Claire exhaled.
“And Price?”
Bell hesitated.
“He’s here.”
“Did he surrender?”
“Not exactly.”
“What happened?”
“He collapsed.”
Dr. Shah came onto the line.
“Cardiac arrest.”
Claire blinked.
“Is he alive?”
“For now.”
Price had ingested something before the meeting.
Poison or medication.
Nobody knew yet.
As paramedics worked on him, he kept trying to speak.
Bell leaned close.
Price managed one sentence.
“Vale has the children.”
Then he lost consciousness.
Click here to continue reading: PART 12: Price’s Final Warning Exposed Where the Active Subjects Had Been Taken, While Sophie Faced the Treatment That Had Nearly Killed Abigail
The Nurse Stopped Smiling Before She Closed the Door, and Claire Knew Sophie’s Routine Blood Test Had Found Something Wrong
Part 11 of 47
